Cathie Wood's $362 Million CRISPR Bet: Hidden Catalyst
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Millennials are reshaping wealth trends with unique financial habits. Discover how these trends impact your financial planning.
17,119 articlesCathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Two popular healthcare ETFs sit at the crossroads of broad exposure and biotech precision. This guide helps you decid...
Looking to secure the best mortgage rate in 2026? This practical guide breaks down the steps that save you money: sha...
Two refining giants posted solid Q4 results, signaling a strong 2026 for the sector. The question on investors’ minds...
A boutique investor firm makes a bold healthcare bet by accumulating over 2 million Baxter International shares. The ...
Rivian faces a challenging journey into 2026, with big questions about profitability, demand, and policy shifts. This...
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
Mativ's 2025 earnings cycle reveals a company navigating macro headwinds with disciplined execution. This article bre...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
The Supreme Court ruled tariffs illegal, removing a key policy tool and shaking markets. Bitcoin price reacts supreme...
Cogent Communications stock crashed after a mixed quarter, delivering a revenue miss despite a narrower loss. This an...
President Trump hikes global tariffs to 15% following a Supreme Court ruling, triggering cost fears for businesses an...